“Consistent Efficacy and Safety in Four Double-Blind, Vehicle-Controlled Studies of Ivermectin 1% Cream in the Treatment of Moderate-to-Severe Papulopustular Rosacea”, J of Skin, vol. 1, no. 3.1, p. s61, Oct. 2017, doi: 10.25251/skin.1.supp.60.